← Back to Search

Stigma-Reduction Training for Opioid Use Disorder

N/A

Recruiting

Led By Berkeley Franz, Ph.D.

Research Sponsored by Ohio University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

Study Summary

This trial tests a training intervention to increase rural primary care providers' willingness to prescribe buprenorphine, a medication for opioid use disorder that may reduce HIV transmission.

Who is the study for?

This trial is for rural healthcare professionals who can legally prescribe buprenorphine, are at least 18 years old, and work in primary care as physicians, nurse practitioners, or physician assistants. It's not for those already prescribing buprenorphine to the maximum number of patients.Check my eligibility

What is being tested?

The study is testing a stigma-reduction training program designed to encourage more rural health care providers to prescribe buprenorphine for opioid use disorder. The goal is to see if this training can change attitudes and increase prescription rates.See study design

What are the potential side effects?

Since the intervention involves educational training rather than medication, there are no direct medical side effects. However, participants may experience changes in beliefs or attitudes about drug use and prescribing practices.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Adoption

Appropriateness

+1 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: InterventionActive Control1 Intervention

Group II: ControlPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor

69 Previous Clinical Trials

36,814 Total Patients Enrolled

Ohio State UniversityOTHER

830 Previous Clinical Trials

505,220 Total Patients Enrolled

Rutgers UniversityOTHER

113 Previous Clinical Trials

2,803,693 Total Patients Enrolled

Media Library

Rural Health Services Clinical Trial 2023: Stigma-reduction training Highlights & Side Effects. Trial Name: NCT05505227 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many applicants are being admitted to participate in this trial?

"Affirmative. The information stored on clinicaltrials.gov implies that this medical trial is currently enrolling patients, having been first published on September 1st, 2022 and recently updated in March 2nd, 2023. This research requires 400 individuals from a single locale to join the study's cohort."

Answered by AI

Is it possible to still participate in this research endeavor?

"Affirmative. Clinicaltrials.gov attests to the fact that this clinical trial is actively recruiting patients, with 400 expected from a single site who have signed up since September 1st 2022 and whose application status has been updated as recently as March 2nd 2023."

Answered by AI